Protalix BioTherapeutics (PLX) Completes Patient Switch from Cerezyme to Taliglucerase Alfa in Gaucher Study
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (AMEX: PLX) announces results from the first 15 patients that completed the Company's nine month, worldwide, multi-center ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
